To evaluate the impact of fibroblast‐specific Has2 deletion on cardiac hypertrophy and vascular density, we performed wheat germ agglutinin (WGA) staining (Figure 5a) and isolectin B4 staining (Figure 5b) 7 days post‐MI. The gene discussed is HAS2; the disease is cardiac hypertrophy.